{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:26:19Z","timestamp":1787660779036,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"National Administration of Traditional Chinese Medicine: 2019 Project of building evidence based practice capacity for TCM","award":["No. 2019XZZX-ZL006"],"award-info":[{"award-number":["No. 2019XZZX-ZL006"]}]},{"name":"Sichuan Provincial Key Discipline Construction Project of Traditional Chinese Medicine-Oncology of TCM","award":["No. 2100601"],"award-info":[{"award-number":["No. 2100601"]}]},{"name":"Sichuan Provincial Administration of Traditional Chinese Medicine: Special Research Project of Traditional Chinese Medicine","award":["NO. 2021ZD003"],"award-info":[{"award-number":["NO. 2021ZD003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40122-021-00330-4","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T03:39:57Z","timestamp":1633405197000},"page":"1673-1689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gabapentin has Longer-Term Efficacy for the Treatment of Chronic Pelvic Pain in Women: A Systematic Review and Pilot Meta-analysis"],"prefix":"10.1007","volume":"10","author":[{"given":"Xiu-Mei","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Feng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7900-4060","authenticated-orcid":false,"given":"Feng-Ming","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"key":"330_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/pcan.2016.8","volume":"19","author":"AS Polackwich","year":"2016","unstructured":"Polackwich AS, Shoskes DA. Chronic prostatitis\/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis. 2016;19:132\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"330_CR2","first-page":"CD012551","volume":"5","author":"JV Franco","year":"2018","unstructured":"Franco JV, Turk T, Jung JH, et al. Non-pharmacological interventions for treating chronic prostatitis\/chronic pelvic pain syndrome. Cochrane Database Syst Rev. 2018;5:CD012551.","journal-title":"Cochrane Database Syst Rev"},{"key":"330_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(20)31693-7","volume":"396","author":"AW Horne","year":"2020","unstructured":"Horne AW, Vincent K, Hewitt CA, et al. Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2020;396:909\u201317.","journal-title":"Lancet"},{"key":"330_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1442-2042.2004.00868.x","volume":"11","author":"H Honjo","year":"2004","unstructured":"Honjo H, Kamoi K, Naya Y, et al. Effects of acupuncture for chronic pelvic pain syndrome with intrapelvic venous congestion: preliminary results. Int J Urol. 2004;11:607\u201312.","journal-title":"Int J Urol"},{"key":"330_CR5","volume-title":"CADTH rapid response reports. Mindfulness training and yoga for the management of chronic non-malignant pain: a review of clinical effectiveness and cost-effectiveness","author":"CC Lachance","year":"2019","unstructured":"Lachance CC, McCormack S. CADTH rapid response reports. Mindfulness training and yoga for the management of chronic non-malignant pain: a review of clinical effectiveness and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2019."},{"key":"330_CR6","first-page":"380","volume":"93","author":"LM Speer","year":"2016","unstructured":"Speer LM, Mushkbar S, Erbele T. Chronic pelvic pain in women. Am Fam Physician. 2016;93:380\u20137.","journal-title":"Am Fam Physician"},{"key":"330_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0268355514568067","volume":"30","author":"MH Meissner","year":"2015","unstructured":"Meissner MH, Gibson K. Clinical outcome after treatment of pelvic congestion syndrome: sense and nonsense. Phlebology. 2015;30:73\u201380.","journal-title":"Phlebology"},{"key":"330_CR8","doi-asserted-by":"publisher","first-page":"FSO148","DOI":"10.4155\/fsoa-2016-0048","volume":"2","author":"ET Carey","year":"2016","unstructured":"Carey ET, As-Sanie S. New developments in the pharmacotherapy of neuropathic chronic pelvic pain. Future Sci OA. 2016;2:FSO148.","journal-title":"Future Sci OA."},{"key":"330_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5604\/12321966.1152094","volume":"22","author":"M Malec-Milewska","year":"2015","unstructured":"Malec-Milewska M, Horosz B, Sekowska A, et al. Pharmacological treatment and regional anesthesia techniques for pain management after completion of both conservative and surgical treatment of endometriosis and pelvic adhesions in women with chronic pelvic pain as a mandated treatment strategy. Ann Agric Environ Med. 2015;22:353\u20136.","journal-title":"Ann Agric Environ Med"},{"key":"330_CR10","first-page":"CD008797","volume":"5","author":"YC Cheong","year":"2014","unstructured":"Cheong YC, Smotra G, Williams AC. Non-surgical interventions for the management of chronic pelvic pain. Cochrane Database Syst Rev. 2014;5:CD008797.","journal-title":"Cochrane Database Syst Rev"},{"key":"330_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neulet.2011.01.072","volume":"492","author":"IK Celikyurt","year":"2011","unstructured":"Celikyurt IK, Mutlu O, Ulak G, Akar FY, Erden F. Gabapentin, a GABA analogue, enhances cognitive performance in mice. Neurosci Lett. 2011;492:124\u20138.","journal-title":"Neurosci Lett"},{"key":"330_CR12","doi-asserted-by":"publisher","first-page":"e0153037","DOI":"10.1371\/journal.pone.0153037","volume":"11","author":"SC Lewis","year":"2016","unstructured":"Lewis SC, Bhattacharya S, Wu O, et al. Gabapentin for the management of chronic pelvic pain in women (GaPP1): a pilot randomised controlled trial. PLoS ONE. 2016;11:e0153037.","journal-title":"PLoS ONE"},{"key":"330_CR13","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00404-019-05272-z","volume":"300","author":"MA AbdelHafeez","year":"2019","unstructured":"AbdelHafeez MA, Reda A, Elnaggar A, El-Zeneiny H, Mokhles JM. Gabapentin for the management of chronic pelvic pain in women. Arch Gynecol Obstet. 2019;300:1271\u20137.","journal-title":"Arch Gynecol Obstet"},{"key":"330_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00508-005-0464-2","volume":"117","author":"SM Sator-Katzenschlager","year":"2005","unstructured":"Sator-Katzenschlager SM, Scharbert G, Kress HG, et al. Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr. 2005;117:761\u20138.","journal-title":"Wien Klin Wochenschr"},{"key":"330_CR15","doi-asserted-by":"publisher","first-page":"102403","DOI":"10.1016\/j.amsu.2021.102403","volume":"66","author":"F Bekele","year":"2021","unstructured":"Bekele F, Mechessa DF, Sefera B. Prevalence and associated factors of the psychological impact of COVID-19 among communities, health care workers and patients in Ethiopia: a systematic review. Ann Med Surg (Lond). 2021;66:102403.","journal-title":"Ann Med Surg (Lond)."},{"key":"330_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777\u201384.","journal-title":"Ann Intern Med"},{"key":"330_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1089\/wound.2021.0067","volume":"10","author":"R Yan","year":"2021","unstructured":"Yan R, Fu X, Ren YF, et al. The analgesic benefits of ketorolac to local anesthetic wound infiltration is statistically significant but clinically unimportant: a comprehensive systematic review and meta-analysis. Adv Wound Care (New Rochelle). 2021;10:583\u201395.","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"330_CR18","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"330_CR19","first-page":"508","volume":"70","author":"M Koperny","year":"2016","unstructured":"Koperny M, Lesniak W, Jankowski M, Bala M. The Cochrane collaboration\u2014the role in the evolution of evidence-based medicine and development of cooperation in Poland. Przegl Epidemiol. 2016;70:508\u201320.","journal-title":"Przegl Epidemiol"},{"key":"330_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2753.2010.01516.x","volume":"18","author":"S Armijo-Olivo","year":"2012","unstructured":"Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract. 2012;18:12\u20138.","journal-title":"J Eval Clin Pract"},{"key":"330_CR21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ. 2008;336:1049\u201351.","journal-title":"BMJ"},{"key":"330_CR22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jbmt.2019.02.009","volume":"23","author":"M Fleischmann","year":"2019","unstructured":"Fleischmann M, Vaughan B. Commentary: Statistical significance and clinical significance\u2014a call to consider patient reported outcome measures, effect size, confidence interval and minimal clinically important difference (MCID). J Bodyw Mov Ther. 2019;23:690\u20134.","journal-title":"J Bodyw Mov Ther"},{"key":"330_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejpain.2003.09.004","volume":"8","author":"F Salaffi","year":"2004","unstructured":"Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8:283\u201391.","journal-title":"Eur J Pain"},{"key":"330_CR24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"330_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","volume":"74","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74:785\u201394.","journal-title":"Biometrics"},{"key":"330_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40122-021-00258-9","volume":"10","author":"H Liu","year":"2021","unstructured":"Liu H, Fu X, Ren YF, et al. Does inhaled methoxyflurane implement fast and efficient pain management in trauma patients? A systematic review and meta-analysis. Pain Ther. 2021;10:651\u201374.","journal-title":"Pain Ther"},{"key":"330_CR27","first-page":"CD007938","volume":"6","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6:CD007938.","journal-title":"Cochrane Database Syst Rev"},{"key":"330_CR28","first-page":"CD007938","volume":"2014","author":"RA Moore","year":"2014","unstructured":"Moore RA, Wiffen PJ, Derry S, Toelle T, Rice AS. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014;2014:CD007938.","journal-title":"Cochrane Database Syst Rev"},{"key":"330_CR29","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jama.2017.21547","volume":"319","author":"A Moore","year":"2018","unstructured":"Moore A, Derry S, Wiffen P. Gabapentin for chronic neuropathic pain. JAMA. 2018;319:818\u20139.","journal-title":"JAMA"},{"key":"330_CR30","doi-asserted-by":"publisher","first-page":"j3520","DOI":"10.1136\/bmj.j3520","volume":"358","author":"AW Horne","year":"2017","unstructured":"Horne AW, Vincent K, Cregg R, Daniels J. Is gabapentin effective for women with unexplained chronic pelvic pain? BMJ. 2017;358:j3520.","journal-title":"BMJ"},{"key":"330_CR31","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1152\/jn.00168.2014","volume":"112","author":"JE Biggs","year":"2014","unstructured":"Biggs JE, Boakye PA, Ganesan N, et al. Analysis of the long-term actions of gabapentin and pregabalin in dorsal root ganglia and substantia gelatinosa. J Neurophysiol. 2014;112:2398\u2013412.","journal-title":"J Neurophysiol"},{"key":"330_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1177\/0194599818768517","volume":"159","author":"AJ Bowen","year":"2018","unstructured":"Bowen AJ, Nowacki AS, Contrera K, et al. Short- and long-term effects of neuromodulators for unexplained chronic cough. Otolaryngol Head Neck Surg. 2018;159:508\u201315.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"330_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0028-3908(00)00103-9","volume":"40","author":"MR Cilio","year":"2001","unstructured":"Cilio MR, Bolanos AR, Liu Z, et al. Anticonvulsant action and long-term effects of gabapentin in the immature brain. Neuropharmacology. 2001;40:139\u201347.","journal-title":"Neuropharmacology"},{"key":"330_CR34","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","volume":"280","author":"M Backonja","year":"1998","unstructured":"Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280:1831\u20136.","journal-title":"JAMA"},{"key":"330_CR35","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/acer.14408","volume":"44","author":"CT Rentsch","year":"2020","unstructured":"Rentsch CT, Morford KL, Fiellin DA, et al. Safety of gabapentin prescribed for any indication in a large clinical cohort of 571,718 US veterans with and without alcohol use disorder. Alcohol Clin Exp Res. 2020;44:1807\u201315.","journal-title":"Alcohol Clin Exp Res"},{"key":"330_CR36","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1046\/j.1528-1157.2002.01702.x","volume":"43","author":"LV Wilton","year":"2002","unstructured":"Wilton LV, Shakir S. A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England. Epilepsia. 2002;43:983\u201392.","journal-title":"Epilepsia"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-021-00330-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-021-00330-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-021-00330-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T16:56:18Z","timestamp":1636649778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-021-00330-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["330"],"URL":"https:\/\/doi.org\/10.1007\/s40122-021-00330-4","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,4]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}